AIDS-Related Kaposis Sarcoma: State of the Art and Therapeutic Strategies

Department of Medical Oncology, National Cancer Institute, Aviano (PN), Italy.
Current HIV research (Impact Factor: 1.76). 11/2009; 7(6):634-8. DOI: 10.2174/157016209789973619
Source: PubMed


In the HAART era Kaposi's sarcoma (KS) remains the second most frequent tumor in HIV-infected patients worldwide, and it has become the most common cancer in Sub-Saharan Africa. In western countries the risk for KS in men having sex with men (MSM) is 5 to 10 times higher compared to other groups of individuals practicing other HIV-risk behaviors. Patients with KS in Sub-Saharan Africa have very high tumor burdens and rapid disease progression with a diminished life expectancy of less than 6 months. KS lesions are comprised of both distinctive spindle cells of endothelial origin and a variable inflammatory infiltrate, which suggests that KS may result from reactive hyperproliferation induced by chronic inflammation, and therefore it is not a true neoplasm. KS has a variable clinical course ranging from very indolent forms, requiring no or minimal therapy, to a rapidly progressive disease. Treatment decisions must take into consideration the extent and the rate of tumor growth, patient's symptoms, immune system conditions and concurrent HIV-related complications. Several different therapeutic options are available but the optimal therapy is still unclear. Highly Active Antiretroviral Therapy (HAART) including protease inhibitors (PI) may represent the first treatment step for slowly progressive disease; chemotherapy (CT) plus HAART is indicated for visceral and/or rapidly progressive disease, whereas maintenance (M)-HAART after systemic chemotherapy may be an effective anti-KS measure after debulking CT. The angiogenic nature of KS makes it particularly suitable for therapies based on targeted agents such as metalloproteinase inhibitors, angiogenesis inhibitors and tyrosine kinase inhibitors. The aim of this article is to provide an up-to-date review of the current status and perspectives of AIDS-related KS in the HAART era.

Download full-text


Available from: Massimiliano Berretta,
125 Reads
  • Source
    • "In any case, the connection between P-TEFb-dependent and HMGA1-dependent signaling via 7SK RNA which we uncovered here represents a new molecular switch (Figure 10). The role that P-TEFb and 7SK RNA play in Tat-dependent HIV transcription (24,66–69) thereby might also provide a molecular explanation for the HIV-associated B-cell lymphoma and Kaposi sarcoma incident rates (70–73). Increased titration of nuclear 7SK RNA into Tat-dependent transcription regulatory complexes will, according to our observations, directly increase HMGA1 activity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Non-coding (nc) RNAs are increasingly recognized to play important regulatory roles in eukaryotic gene expression. The highly abundant and essential 7SK ncRNA has been shown to negatively regulate RNA Polymerase II transcription by inactivating the positive transcription elongation factor b (P-TEFb) in cellular and Tat-dependent HIV transcription. Here, we identify a more general, P-TEFb-independent role of 7SK RNA in directly affecting the function of the architectural transcription factor and chromatin regulator HMGA1. An important regulatory role of 7SK RNA in HMGA1-dependent cell differentiation and proliferation regulation is uncovered with the identification of over 1500 7SK-responsive HMGA1 target genes. Elevated HMGA1 expression is observed in nearly every type of cancer making the use of a 7SK substructure in the inhibition of HMGA1 activity, as pioneered here, potentially useful in therapy. The 7SK-HMGA1 interaction not only adds an essential facet to the comprehension of transcriptional plasticity at the coupling of initiation and elongation, but also might provide a molecular link between HIV reprogramming of cellular gene expression-associated oncogenesis.
    Nucleic Acids Research 11/2010; 39(6):2057-72. DOI:10.1093/nar/gkq1153 · 9.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The coupling coefficient and resonant frequency shift of dual modes induced by the internal perturbation are obtained theoretically for a general circular resonator. They are used for the design of a two-stage BPF together with the external Q also theoretically derived. The frequency and the appearance condition of the intrinsic attenuation poles at both sides of the passband are analyzed in a simple form
    Microwave Conference Proceedings, 1997. APMC '97, 1997 Asia-Pacific; 01/1998
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent developments in Si based tunnel diode technologies have made the realization of circuits incorporating both tunnel diodes and transistors feasible. A recent study by the authors presented the design of an n-on-p Si RITD layer with a peak-to-valley current ratio (PVCR) of 2.15 at a current density of 3 kA/cm<sup>2</sup> which was grown by molecular beam epitaxy (MBE) (Thompson et al, Appl. Phys. Lett. vol. 75, pp. 1308-1310, 1999). Further studies of this structure investigated additional tunnel barrier thicknesses of 4 nm, 8 nm, and 10 nm. In all samples, room temperature NDR was observed comparable to that of the baseline 6 nm RITD. Simple adjustments to the tunnel barrier thickness can be made to tailor the performance for a particular circuit application. However, growth of a complimentary p-on-n tunnel diode is problematic due to Sb segregation through the intrinsic tunneling spacer. The solution is to control the Sb segregation by employing multiple substrate temperatures during MBE growth. Following the success of the complementary p-on-n growth strategy, it was now possible to demonstrate the integration of two tunnel diodes in a single growth. The basic flow and design presented here follow that of III-V RITDs (Yang et al, 1995), presenting a symmetric pnp RITD structure. The motivation for developing this structure was to mimic the I-V characteristic of III-V RITDs which have NDR regions under forward and reverse bias. A Si-based structure with these properties would facilitate the development of a Goto-type memory cell (Goto et al, 1960)
    Device Research Conference, 2000. Conference Digest. 58th DRC; 02/2000
Show more